coin-img-ETHETH+1.88%coin-img-BTCBTC+0.60%coin-img-SOLSOL+4.58%coin-img-CTMCTM+1.17%coin-img-USDCUSDC-0.02%coin-img-XRPXRP+0.63%coin-img-HYPEHYPE+8.07%coin-img-TRXTRX-0.62%coin-img-ETHETH+1.88%coin-img-BTCBTC+0.60%coin-img-SOLSOL+4.58%coin-img-CTMCTM+1.17%coin-img-USDCUSDC-0.02%coin-img-XRPXRP+0.63%coin-img-HYPEHYPE+8.07%coin-img-TRXTRX-0.62%coin-img-ETHETH+1.88%coin-img-BTCBTC+0.60%coin-img-SOLSOL+4.58%coin-img-CTMCTM+1.17%coin-img-USDCUSDC-0.02%coin-img-XRPXRP+0.63%coin-img-HYPEHYPE+8.07%coin-img-TRXTRX-0.62%coin-img-ETHETH+1.88%coin-img-BTCBTC+0.60%coin-img-SOLSOL+4.58%coin-img-CTMCTM+1.17%coin-img-USDCUSDC-0.02%coin-img-XRPXRP+0.63%coin-img-HYPEHYPE+8.07%coin-img-TRXTRX-0.62%
user-avatar
CNBC

FDA picks Eli Lilly, Regeneron and five others for PreCheck pilot to speed reviews of new drug plants

Eli Lilly and Regeneron are among the first seven companies selected by the U.S. Food and Drug Administration for its PreCheck Pilot Program, CNBC reported. The initiative is aimed at accelerating regulatory reviews of new domestic pharmaceutical manufacturing facilities.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.
Stocks